Galecto Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares for Gross Proceeds of $316.3 Million Benzinga · 2026-02-12 GLTO
Galecto Announces Pricing of $275 Million Underwritten Public Offering GlobeNewswire Inc. · 2026-02-11 GLTO
Galecto, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire Inc. · 2025-12-16 GLTO
Galecto Stock Soars: Strengthens Blood Cancer Pipeline With Damora Therapeutics Deal, Secures Fresh Funding To 2029 Benzinga · 2025-11-10 GLTO